Takao Takase

Ultra-high-dose methylcobalamin in amyotrophic lateral sclerosis: a long-term phase II/III randomised controlled study

Ryuji Kaji, Takashi Imai, Yasuo Iwasaki et al. · Journal of Neurology Neurosurgery & Psychiatry · 2019 · 79 citations · Full text

Medicine, Neurology, Pharmacotherapy +14

Open‐label study to investigate the safety and efficacy of adjunctive perampanel in pediatric patients (4 to <12 years) with inadequately controlled focal seizures or generalized tonic‐clonic seizures

András Fogarasi, Robert Flamini, Mathieu Milh et al. · Epilepsia · 2020 · 61 citations · Full text

Medicine, Neurology, Pharmacology +17

Efficacy and Safety of Sustained Release Donepezil High Dose versus Immediate Release Donepezil Standard Dose in Japanese Patients with Severe Alzheimer’s Disease: A Randomized, Double-Blind Trial

Akira Homma, Hirotsugu Atarashi, Naoki Kubota et al. · Journal of Alzheimer s Disease · 2016 · 33 citations

Medicine, Pharmacology, Pharmacotherapy +17

Long-Term Safety and Efficacy of Donepezil in Patients with Severe Alzheimer’s Disease: Results from a 52-Week, Open-Label, Multicenter, Extension Study in Japan

Akira Homma, Yukimichi Imai, Hisao Tago et al. · Dementia and Geriatric Cognitive Disorders · 2009 · 28 citations

Medicine, Pharmacology, Pharmacotherapy +17

Effects of eszopiclone on safety, subjective measures of efficacy, and quality of life in elderly and nonelderly Japanese patients with chronic insomnia, both with and without comorbid psychiatric disorders: a 24-week, randomized, double-blind study

Naohisa Uchimura, Atsushi Kamijo, Takao Takase · Annals of General Psychiatry · 2012 · 19 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17